Amarin (United Kingdom)
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Amarin (United Kingdom), United Kingdom, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
78%
Total
Publications
178
Total Open
Publications
138
Total
Citations
1.8K
Open Access
Percentage
78%
Total
Publications
178
Total Open
Publications
138
Total
Citations
1.8K
Breakdown
Publisher Open
64%
Both
13%
Other Platform Open
1%
Closed
22%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 7%
9
Hybrid 80%
109
No Guarantees 13%
18
Other Platform Open
Domain 84%
21
Institution 40%
10
Public 8%
2
Preprint 4%
1
Other Internet 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 19 |
Europe PMC | Domain | 12 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 3 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 2 |
University of Dundee - Discovery Research Portal | Institution | 2 |
Semantic Scholar | Public | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inria | Institution | 2 |
BRAC University - BRAC University Institutional Repository | Institution | 2 |
whiterose.ac.uk OAI-PMH Repository | Institution | 1 |
Università degli Studi di Brescia - Institutional Research Information System | Institution | 1 |